Skip to main content
Top
Published in: Journal of Neuro-Oncology 3/2013

Open Access 01-07-2013 | Clinical Study

Tumor origin and growth pattern at diagnosis and surgical hypothalamic damage predict obesity in pediatric craniopharyngioma

Authors: Seung Wan Park, Hae Woon Jung, Young Ah Lee, Choong Ho Shin, Sei Won Yang, Jung-Eun Cheon, In-One Kim, Ji Hoon Phi, Seung-Ki Kim, Kyu-Chang Wang

Published in: Journal of Neuro-Oncology | Issue 3/2013

Login to get access

Abstract

Severe obesity is a major problem in pediatric craniopharyngioma. We investigated whether tumor origin, growth pattern, and surgical damage predict obesity in pediatric craniopharyngioma. Subjects were 58 patients (30 males) with no tumor recurrence during the first postoperative 18 months. Preoperative hypothalamic involvement was classified into no (pre_G0, n = 19), little (pre_G1, n = 21), and severe (pre_G2, n = 18) involvement groups based on sub- or supradiaphragmatic tumor origin and growth patterns. Postoperative hypothalamic involvement was classified into no (post_G0, n = 4), minimal (post_G1, n = 19), and significant (post_G2, n = 35) involvement groups according to follow-up imaging. The prevalence of obesity increased from 13.2 % at diagnosis (mean age = 8.1 years) to 37.9 % at last follow-up (mean duration = 9.1 years). Only the body mass index (BMI) Z-score increment of the first postoperative year (first-year ΔBMI_Z) was significant (P = 0.007). Both the preoperative BMI_Z (P = 0.001) and the first-year ΔBMI_Z (P = 0.017) showed an increasing trend from the pre_G0 to pre_G1 to pre_G2 group. For the 40 patients with pre_G0 or pre_G1, the first-year ΔBMI_Z was higher in the post_G2 group than the post_G1 group (0.02 ± 0.91 vs. 0.89 ± 0.72, P = 0.003). Tumor origin and growth pattern affect preoperative BMI_Z and postoperative weight gain. Despite little or no hypothalamic involvement at diagnosis, surgical damage contributes to postoperative weight gain in patients with craniopharyngioma.
Literature
1.
go back to reference Muller HL (2010) Childhood craniopharyngioma—current concepts in diagnosis, therapy and follow-up. Nat Rev Endocrinol 6:609–618PubMedCrossRef Muller HL (2010) Childhood craniopharyngioma—current concepts in diagnosis, therapy and follow-up. Nat Rev Endocrinol 6:609–618PubMedCrossRef
2.
go back to reference Müller HL, Gebhardt U, Teske C, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Pohl F, Sörensen N, Calaminus G; Study Committee of KRANIOPHARYNGEOM 2000 (2011) Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3 year follow-up. Eur J Endocrinol 165:17–24 Müller HL, Gebhardt U, Teske C, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Pohl F, Sörensen N, Calaminus G; Study Committee of KRANIOPHARYNGEOM 2000 (2011) Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3 year follow-up. Eur J Endocrinol 165:17–24
3.
go back to reference Holmer H, Ekman B, Björk J, Nordstöm CH, Popovic V, Siversson A, Erfurth EM (2009) Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy. Eur J Endocrinol 161:671–679PubMedCrossRef Holmer H, Ekman B, Björk J, Nordstöm CH, Popovic V, Siversson A, Erfurth EM (2009) Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy. Eur J Endocrinol 161:671–679PubMedCrossRef
4.
go back to reference Kendall-Taylor P, Jönsson PJ, Abs R, Erfurth EM, Koltowska-Häggström M, Price DA, Verhelst J (2005) The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. Eur J Endocrinol 152:557–567PubMedCrossRef Kendall-Taylor P, Jönsson PJ, Abs R, Erfurth EM, Koltowska-Häggström M, Price DA, Verhelst J (2005) The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. Eur J Endocrinol 152:557–567PubMedCrossRef
5.
go back to reference Müller HL, Emser A, Faldum A, Bruhnken G, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, Sörensen N (2004) Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab 89:3298–3305PubMedCrossRef Müller HL, Emser A, Faldum A, Bruhnken G, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, Sörensen N (2004) Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab 89:3298–3305PubMedCrossRef
6.
go back to reference Vinchon M, Weill J, Delestret I, Dhellemmes P (2009) Craniopharyngioma and hypothalamic obesity in children. Childs Nerv Syst 25:347–352PubMedCrossRef Vinchon M, Weill J, Delestret I, Dhellemmes P (2009) Craniopharyngioma and hypothalamic obesity in children. Childs Nerv Syst 25:347–352PubMedCrossRef
7.
go back to reference Müller HL, Faldum A, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, Sörensen N (2003) Functional capacity, obesity and hypothalamic involvement: cross-sectional study on 212 patients with childhood craniopharyngioma. Klin Padiatr 215:310–314PubMedCrossRef Müller HL, Faldum A, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, Sörensen N (2003) Functional capacity, obesity and hypothalamic involvement: cross-sectional study on 212 patients with childhood craniopharyngioma. Klin Padiatr 215:310–314PubMedCrossRef
8.
go back to reference Sherlock M, Ayuk J, Tomlinson JW, Toogood AA, Aragon-Alonso A, Sheppard MC, Bates AS, Stewart PM (2010) Mortality in patients with pituitary disease. Endocr Rev 31:301–342PubMedCrossRef Sherlock M, Ayuk J, Tomlinson JW, Toogood AA, Aragon-Alonso A, Sheppard MC, Bates AS, Stewart PM (2010) Mortality in patients with pituitary disease. Endocr Rev 31:301–342PubMedCrossRef
9.
go back to reference Müller HL, Bueb K, Bartels U, Roth C, Harz K, Graf N, Korinthenberg R, Bettendorf M, Kühl J, Gutjahr P, Sörensen N, Calaminus G (2001) Obesity after childhood craniopharyngioma–German multicenter study on pre-operative risk factors and quality of life. Klin Padiatr 213:244–249PubMedCrossRef Müller HL, Bueb K, Bartels U, Roth C, Harz K, Graf N, Korinthenberg R, Bettendorf M, Kühl J, Gutjahr P, Sörensen N, Calaminus G (2001) Obesity after childhood craniopharyngioma–German multicenter study on pre-operative risk factors and quality of life. Klin Padiatr 213:244–249PubMedCrossRef
10.
go back to reference de Vile CJ, Grant DB, Hayward RD, Kendall BE, Neville BG, Stanhope R (1996) Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging. J Clin Endocrinol Metab 81:2734–2737PubMedCrossRef de Vile CJ, Grant DB, Hayward RD, Kendall BE, Neville BG, Stanhope R (1996) Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging. J Clin Endocrinol Metab 81:2734–2737PubMedCrossRef
11.
go back to reference Puget S, Garnett M, Wray A, Grill J, Habrand JL, Bodaert N, Zerah M, Bezerra M, Renier D, Pierre-Kahn A, Sainte-Rose C (2007) Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg 106(1 Suppl):3–12PubMed Puget S, Garnett M, Wray A, Grill J, Habrand JL, Bodaert N, Zerah M, Bezerra M, Renier D, Pierre-Kahn A, Sainte-Rose C (2007) Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg 106(1 Suppl):3–12PubMed
12.
go back to reference Wang KC, Hong SH, Kim SK, Cho BK (2005) Origin of craniopharyngiomas: implication on the growth pattern. Childs Nerv Syst 21:628–634PubMedCrossRef Wang KC, Hong SH, Kim SK, Cho BK (2005) Origin of craniopharyngiomas: implication on the growth pattern. Childs Nerv Syst 21:628–634PubMedCrossRef
13.
go back to reference Moon JS, Lee SY, Nam CM, Choi JM, Choe BK, Seo JW, Oh KW, Jang MJ, Hwang SS, Yoo MH, Kim YT, Lee CG (2008) 2007 Korean National Growth Charts: review of developmental process and an outlook. Korean J Pediatr 51:1–25CrossRef Moon JS, Lee SY, Nam CM, Choi JM, Choe BK, Seo JW, Oh KW, Jang MJ, Hwang SS, Yoo MH, Kim YT, Lee CG (2008) 2007 Korean National Growth Charts: review of developmental process and an outlook. Korean J Pediatr 51:1–25CrossRef
14.
go back to reference Muller HL (2011) Consequences of craniopharyngioma surgery in children. J Clin Endocrinol Metab 96:1981–1991PubMedCrossRef Muller HL (2011) Consequences of craniopharyngioma surgery in children. J Clin Endocrinol Metab 96:1981–1991PubMedCrossRef
15.
go back to reference Meuric S, Brauner R, Trivin C, Souberbielle JC, Zerah M, Sainte-Rose C (2005) Influence of tumor location on the presentation and evolution of craniopharyngiomas. J Neurosurg 103(5 Suppl):421–426PubMed Meuric S, Brauner R, Trivin C, Souberbielle JC, Zerah M, Sainte-Rose C (2005) Influence of tumor location on the presentation and evolution of craniopharyngiomas. J Neurosurg 103(5 Suppl):421–426PubMed
16.
go back to reference Lee M, Korner J (2009) Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans. Pituitary 12:87–95PubMedCrossRef Lee M, Korner J (2009) Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans. Pituitary 12:87–95PubMedCrossRef
18.
go back to reference Ahmet A, Blaser S, Stephens D, Guger S, Rutkas JT, Hamilton J (2006) Weight gain in craniopharyngioma—a model for hypothalamic obesity. J Pediatr Endocrinol Metab 19:121–127PubMedCrossRef Ahmet A, Blaser S, Stephens D, Guger S, Rutkas JT, Hamilton J (2006) Weight gain in craniopharyngioma—a model for hypothalamic obesity. J Pediatr Endocrinol Metab 19:121–127PubMedCrossRef
19.
go back to reference Müller HL, Heinrich M, Bueb K, Etavard-Gorris N, Gebhardt U, Kolb R, Sörensen N (2003) Perioperative dexamethasone treatment in childhood craniopharyngioma—influence on short-term and long-term weight gain. Exp Clin Endocrinol Diabetes 111:330–334PubMedCrossRef Müller HL, Heinrich M, Bueb K, Etavard-Gorris N, Gebhardt U, Kolb R, Sörensen N (2003) Perioperative dexamethasone treatment in childhood craniopharyngioma—influence on short-term and long-term weight gain. Exp Clin Endocrinol Diabetes 111:330–334PubMedCrossRef
20.
go back to reference Kołtowska-Häggström M, Geffner ME, Jönsson P, Monson JP, Abs R, Hána V, Höybye C, Wollmann HA (2010) Discontinuation of growth hormone (GH) treatment during the transition phase is an important factor determining the phenotype of young adults with nonidiopathic childhood-onset GH deficiency. J Clin Endocrinol Metab 95:2646–2654PubMedCrossRef Kołtowska-Häggström M, Geffner ME, Jönsson P, Monson JP, Abs R, Hána V, Höybye C, Wollmann HA (2010) Discontinuation of growth hormone (GH) treatment during the transition phase is an important factor determining the phenotype of young adults with nonidiopathic childhood-onset GH deficiency. J Clin Endocrinol Metab 95:2646–2654PubMedCrossRef
21.
go back to reference Ergun-Longmire B, Mertens AC, Mitby P, Qin J, Heller G, Shi W, Yasui Y, Robison LL, Sklar CA (2006) Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab 91:3494–3498PubMedCrossRef Ergun-Longmire B, Mertens AC, Mitby P, Qin J, Heller G, Shi W, Yasui Y, Robison LL, Sklar CA (2006) Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab 91:3494–3498PubMedCrossRef
Metadata
Title
Tumor origin and growth pattern at diagnosis and surgical hypothalamic damage predict obesity in pediatric craniopharyngioma
Authors
Seung Wan Park
Hae Woon Jung
Young Ah Lee
Choong Ho Shin
Sei Won Yang
Jung-Eun Cheon
In-One Kim
Ji Hoon Phi
Seung-Ki Kim
Kyu-Chang Wang
Publication date
01-07-2013
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 3/2013
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-013-1128-0

Other articles of this Issue 3/2013

Journal of Neuro-Oncology 3/2013 Go to the issue